Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duerwei Capsule for Soft Tissue Injury (Blood Stasis Syndrome)
CTR20140340Phase 3Active
- Sponsor
- Gansu Duyiwei Pharmaceutical
- Start
- Jan 2015
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Duerwei Capsule in soft tissue injury, blood stasis syndrome (BSS), sponsored by Gansu Duyiwei Pharmaceutical. Started Jan 2015; status: active.
02
Drugs
Duerwei Capsule
03
Conditions
soft tissue injuryblood stasis syndrome (BSS)
Beyond the preview
Go deeper on CTR20140340.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140340.